Uncomplicated Falciparum Malaria
9
0
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
33%
3 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of Antimalarials
Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia
A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan
Efficacy and Safety of ASAQ and PD for the Treatment of Uncomplicated Falciparum Malaria in Mainland Tanzania
Arterolane-PQP Versus DHA-PQP in Uncomplicated Falciparum Malaria in Eastern Myanmar
Efficacy and Safety of Artesunate-amodiaquine-methylene for Malaria Treatment in Children
Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in Bangladesh
Trial of Artesunate Combination Therapy in Pakistan
Effectiveness of Artemisinin Combination Regimens in Falciparum Malaria